Nitroso

In the rapidly advancing pharmaceutical industry, ensuring the safety and efficacy of drugs is essential. A critical focus area is the control of impurities, particularly nitroso impurities, which can impact drug safety. Sumatriptan, a widely prescribed migraine medication, is known to develop a specific nitroso impurity that has raised concerns among regulators and pharmaceutical companies.

Medications play a crucial role in managing various health conditions, from hypertension to attention deficit hyperactivity disorder (ADHD). However, the presence of impurities in these drugs can pose significant risks to patient safety. One such impurity, N-nitroso-clonidine, has recently raised concerns among healthcare professionals and regulatory authorities worldwide. At Aquigen Bio Sciences, the leading Contract